Universitäres Centrum für Tumorerkrankungen Mainz (UCT Mainz)
Klinisch orientierter Schwerpunkt / Johannes Gutenberg-Universität Mainz
Bostel, Tilman; Wollschlaeger, Daniel; Nikolaidou, Eirini et al.
Palliative Effects and Complications after Radiotherapy of spinal Bone Lesions in elderly Patients with Multiple MyelomaSTRAHLENTHERAPIE UND ONKOLOGIE. Bd. 199. 2023 S. S163-S163
Schmalfeldt, Barbara; Schmidberger, Heinz
Paradigm shift in endometrial cancerONKOLOGIE. Bd. 29. H. 5. 2023 S. 386-387
Kreipe, Hans; Schmidt, M
Pathologie, Prognose und PrädiktionUntch, Harbeck, Thomssen, Lüftner (Hrsg). Colloquium Senologie. München: Lukon 2023
Singer, Susanne; Bergelt, Corinna; Tribius, Silke et al.
Patient-reported outcomes in head and neck cancer treatment: relevance, challenges, and benefitHNO. 2023
Bonifacius, Agnes; Lamottke, Britta; Tischer-Zimmermann, Sabine et al.
Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donorsJOURNAL OF CLINICAL INVESTIGATION. Bd. 133. H. 12. 2023
Schmidt, Marcus; Denkert, Carsten; Rhiem, Kerstin et al.
Personalized medicine-from translational research to clinical practiceGYNAKOLOGIE. Bd. 56. H. 5. 2023 S. 341-346
Depenbusch, Johanna; Sweegers, Maike G.; Aaronson, Neil K. et al.
PERSPECTIVEs on supervised exercise programs in people with metastatic breast cancer- a qualitative study in four European countriesSUPPORTIVE CARE IN CANCER. Bd. 31. H. 5. 2023
Brose, Alexander; Michalski, Kerstin; Ruf, Juri et al.
PET/CT reading for relapse in non-small cell lung cancer after chemoradiotherapy in the PET-Plan trial cohortCANCER IMAGING. Bd. 23. H. 1. 2023
Nastoupil, Loretta J.; Hess, Georg; Pavlovsky, Miguel A. et al.
Phase 3 SELENE study: ibrutinib plus BR/R-CHOP in previously treated patients with follicular or marginal zone lymphomaBLOOD ADVANCES. Bd. 7. H. 22. 2023 S. 7141-7150
Maas, Anne; Maurice-Stam, Heleen M.; van der Aa-van Delden, Alied C. et al.
Positive and negative survivor-specific psychosocial consequences of childhood cancer: the DCCSS-LATER 2 psycho-oncology studyJOURNAL OF CANCER SURVIVORSHIP. 2023